Takuya Mori
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Neurology top 10%
- Barrier Structure and Function Studies
Papers in
- Co-authors
- Hiroki Kuniyasu (23 shared papers)Rina Fujiwara‐Tani (23 shared papers)Shingo Kishi (22 shared papers)Tohru Funahashi (9 shared papers)Iichiro Shimomura (9 shared papers)Norikazu Maeda (9 shared papers)Hitoshi Ohmori (18 shared papers)Isao Kawahara (18 shared papers)
- Journals
- International Journal of Molecular Sciences (8 papers)PLoS ONE (5 papers)Pathobiology (4 papers)Oncotarget (3 papers)Cancer Science (3 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Takuya Mori
49 papers receiving 878 citations
Peers
Comparison fields: 5 of 107
- Cancer Research 142
- Neurology 69
- Cardiology and Cardiovascular Medicine 167
- Physiology 182
- Epidemiology 223
Countries citing papers authored by Takuya Mori
This map shows the geographic impact of Takuya Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Mori more than expected).
Fields of papers citing papers by Takuya Mori
This network shows the impact of papers produced by Takuya Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Mori. The network helps show where Takuya Mori may publish in the future.
Co-authors
The 25 scholars most cited alongside Takuya Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 96 | |
| 2 | 2014 | 83 | |
| 3 | 2013 | 40 | |
| 4 | 2013 | 37 | |
| 5 | 2011 | 35 | |
| 6 | 2020 | 34 | |
| 7 | 2022 | 32 | |
| 8 | 2018 | 31 | |
| 9 | General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs. | 1985 | 30 |
| 10 | 2019 | 29 | |
| 11 | 2003 | 29 | |
| 12 | 2014 | 25 | |
| 13 | 2020 | 23 | |
| 14 | 2020 | 23 | |
| 15 | 2017 | 23 | |
| 16 | 2019 | 23 | |
| 17 | 2019 | 22 | |
| 18 | 2005 | 22 | |
| 19 | 2020 | 21 | |
| 20 | 2019 | 20 |
About Takuya Mori
Takuya Mori is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Epidemiology, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 51 papers that have together received 894 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Adipose Tissue and Metabolism (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Barrier Structure and Function Studies (5 papers), Muscle metabolism and nutrition (3 papers), Infective Endocarditis Diagnosis and Management (3 papers), Cancer-related molecular mechanisms research (3 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). The work is most often cited by research in Cancer Research (142 citations), Neurology (69 citations), Cardiology and Cardiovascular Medicine (167 citations), Physiology (182 citations) and Epidemiology (223 citations). Takuya Mori has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Hiroki Kuniyasu, Rina Fujiwara‐Tani, Shingo Kishi, Tohru Funahashi, Iichiro Shimomura, Norikazu Maeda, Hitoshi Ohmori, Isao Kawahara, Takamitsu Sasaki and Shiori Mori. Their work appears in journals such as International Journal of Molecular Sciences, PLoS ONE, Pathobiology, Oncotarget and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.